Indanedione anticoagulants


General information

Indanediones have the same mechanism of action as the coumarins. However, they are generally more toxic than the coumarins, and can cause allergic reactions capable of involving many organs and sometimes resulting in death [ ]. These reactions are mainly observed with phenindione and are very rare with other indanediones, such as fluindione.

In an MRC trial, there was a 2.25% incidence of reactions, which necessitated withdrawal of phenindione [ ].

Organs and systems

Cardiovascular

As with the coumarins, the main complication of the indanediones is bleeding. The incidence of hemorrhage varies, depending on age, the intensity of treatment, and the indication. Hematuria, bruising, and gastrointestinal bleeding are the commonest signs. The most common site of fatal hemorrhage is intracranial [ ].

Hematologic

Agranulocytosis can occur during the first month of treatment with phenindione [ ]. Anemia, thrombocytopenia [ ], and leukemoid reactions [ ] have also been described.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here